Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against carbon tetrachloride toxicity in mouse livers

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 6, 2007, Pages 1108-1112

  Chiu, Po Yee ^a   Leung, Hoi Yan ^a   Siu, Ada Hoi Ling ^a   Poon, Michel Kong Tat ^a   Ko, Kam Ming ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Calcium; Carbon tetrachloride; Liver; Mitochondria; Permeability transition; Schisandrin B

Indexed keywords

CALCIUM ION; CARBON TETRACHLORIDE; CYTOCHROME C; DIBENZOCYCLOOCTADIENE DERIVATIVE; LIVER PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SCHISANDRIN B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; LIVER MITOCHONDRION; LIVER PROTECTION; LIVER TOXICITY; MITOCHONDRION; MOUSE; MOUSE STRAIN; NONHUMAN; SCHISANDRACEAE; SINGLE DRUG DOSE;

ANIMALS; CALCIUM; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; CELL MEMBRANE PERMEABILITY; CYCLOOCTANES; CYTOCHROMES C; FEMALE; IONS; LIGNANS; MEMBRANE POTENTIALS; MICE; MICE, INBRED BALB C; MITOCHONDRIA, LIVER; MOLECULAR STRUCTURE; POLYCYCLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 34250018342     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1108     Document Type: Article

References (27)

1. Ko R. K. M., Mak D. H. F., "Modern Herbal Medicine: Molecular Basis in Health & Disease Management," ed. by Packer L., Halliwell B., Ong C. N., Marcel Dekker, New York, 2004, pp. 289-314.
2. Ip S. P., Poon M. K. T., Wu S. S., Che C. T., Ng K. H., Kong Y. C., Ko K. M., Planta Med., 61, 398-401 (1995).
3. Ip S. P., Ko K. M., Biochem. Pharmacol., 52, 1687-1693 (1996).
4. Ip S. P., Ma C. Y., Che C. T., Ko K. M., Biochem. Pharmacol., 54, 317-319 (1997).
5. Chiu P. Y., Tang M. H., Mak D. H. F., Poon M. K. T., Ko K. M., Free Radic. Biol. Med., 35, 368-380 (2003).
6. Tsujimoto Y., Shimizu S., Apoptosis (in press).
7. Honda H. M., Ping P., Cardivasc. Drugs Ther. (in press).
8. Al Nasser I., Crompton M., Biochem. J., 239, 19-29 (1986).
9. Lemasters J. J., Nieminen A. L., Qian T., Trost L. C., Elmore S. P., Nishimura Y., Crowe R. A., Cascio W. E., Bradham C. A., Brenner D. A., Herman B., Biochim. Biophys. Acta, 1366, 177-196 (1998).
10. Redegeld F. A., Moison R. M., Koster A. S., Noordhoek J., Eur. J. Pharmacol., 228, 229-236 (1992).
11. Green D. R., Reed J. C., Science, 281, 1309-1312 (1998).
12. Kang P. M., Haunstetter A., Aoki H., Usheva A., Izumo S., Circ. Res., 87, 118-125 (2000).
13. Bernardi P., Physiol. Rev., 79, 1127-1155 (1999).
14. Fontaine E., Bernardi P., J. Bioenerg. Biomembr., 31, 335-345 (1999).
15. Chiu P. Y., Leung H. Y., Poon M. K. T., Ko K. M., Biogerontology, 7, 199-210 (2006).
16. Demin O. V., Kholodenko B. N., Skulachev V. P., Mol. Cell. Biochem., 184, 21-33 (1998).
17. Tomasi A., Albano E., Banni S., Botti B., Corongiu F., Dessi M. A., Iannone A., Vannini V., Dianzani M. U., Biochem. J., 246, 313-317 (1987).
18. Kroemer G., Dallaporta B., Resche-Rigon M., Annu. Rev. Physiol., 60, 619-642 (1998).
19. Stavrovskaya I. G., Kristal B. S., Free Radic. Biol. Med., 38, 687-697 (2005).
20. Crompton M., Curr. Med. Chem., 10, 1473-1484 (2003).
21. Galat A., Metcalfe S. M., Prog. Biophys. Mol. Biol., 63, 67-118 (1995).
22. Brookes P. S., Yoon Y., Robotham J. L., Anders M. W., Sheu S. S., Am. J. Physiol. Cell Physiol., 287, C817-C833 (2004).
23. Lowrey K., Glende E. A., Jr., Recknagel R. O., Toxicol. Appl. Pharmacol., 59, 389-394 (1981).
24. Grover G. J., Dzwonczyk, S., Sleph, P. G., J. Cardiovasc. Pharmacol., 16, 783-789 (1990).
25. Gunter T. E., Pfeiffer D. R., Am. J. Physiol., 258, C755-C786 (1990).
26. Kushnareva Y. E., Sokolove P. M., Arch. Biochem. Biophys., 376, 377-388 (2000).
27. Crompton M., Costi A., Biochem. J., 266, 33-39 (1990).